Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) FCF Margin (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed FCF Margin for 13 consecutive years, with 17.32% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 1939.0% to 17.32% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13.88% through Dec 2025, down 957.0% year-over-year, with the annual reading at 13.88% for FY2025, 957.0% down from the prior year.
  • FCF Margin hit 17.32% in Q4 2025 for STRATA Skin Sciences, down from 0.35% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 13.19% in Q2 2021 to a low of 34.48% in Q1 2023.
  • Historically, FCF Margin has averaged 11.19% across 5 years, with a median of 10.53% in 2025.
  • Biggest five-year swings in FCF Margin: surged 1649bps in 2024 and later tumbled -2745bps in 2025.
  • Year by year, FCF Margin stood at 5.09% in 2021, then plummeted by -182bps to 14.34% in 2022, then skyrocketed by 72bps to 3.99% in 2023, then skyrocketed by 152bps to 2.08% in 2024, then tumbled by -933bps to 17.32% in 2025.
  • Business Quant data shows FCF Margin for SSKN at 17.32% in Q4 2025, 0.35% in Q3 2025, and 24.53% in Q2 2025.